SAN DIEGO, Aug. 9 /PRNewswire/ -- Genomatica, Inc., a leading systems biology company addressing metabolism-driven product opportunities announced today it has entered into a multi-year collaboration and license agreement with Unilever, a global manufacturer of leading brands in foods, home care and personal care. This new agreement expands on projects the two companies started working together on in 2005. Under the latest collaboration, the companies will be working closely together to take advantage of Genomatica’s unique metabolic modeling and simulation technologies to accelerate the development of novel ingredients to improve the effectiveness of Unilever products. The Metabolic models developed by Genomatica will be tightly integrated with experimental and domain expertise at Unilever to create a powerful integrated discovery platform that the companies will use together to accelerate and enable product R&D efforts at Unilever. Financial details of the agreement were not disclosed, but include research and development support, technology license fees, and milestone payments with Genomatica retaining commercial rights to discoveries for applications outside of Unilever’s fields of interest.
“We are excited to be partnering with a company whose products have such a significant positive impact on the day-to-day lives of consumers world-wide,” commented Christophe H. Schilling, Ph.D., President and Chief Scientific Officer at Genomatica. “Over the years we have established our technology for engineering metabolism to produce valuable bio-derived products, and are now taking strides together with Unilever to expand the application range to aid in the development of next generation home and personal care products. Unilever has recognized the need to capitalize on our systems biology approaches to guide the development of novel products, and we look forward to a productive and fruitful collaboration with the Unilever team.”
“Unilever is very excited at the prospect of working with Genomatica in this cutting edge area of science and using open innovation to engage with the new ways of working which Genomatica will bring to our product design,” says Dominic Tildesley, Chief Scientist for Home and Personal Care of Unilever.
About Unilever
Unilever’s mission is to add vitality to life. We meet everyday needs for nutrition, hygiene and personal care with brands that help people feel good, look good and get more out of life. Unilever is one of the world’s leading suppliers of fast moving consumer goods with strong local roots in more than 100 countries across the globe. Its portfolio includes some of the world’s best known and most loved brands including twelve euro 1 billion brands and global leadership in many categories in which the company operates. The portfolio features brand icons such as Lipton, Knorr, Hellmann’s, Dove, Axe, Omo, Domestos, Pond’s and Bertolli. Unilever has around 206,000 employees in approaching 100 countries and generated annual sales of euro 40 billion in 2005. For more information about Unilever and its brands, please visit www.unilever.com.
About Genomatica
Genomatica is an innovative biotechnology company that possesses proprietary technologies to transform the design, engineering, and manipulation of living cells for the production of valuable biological and chemical products. Genomatica is dedicated to developing and commercializing these high throughput research technologies to address metabolism-driven product opportunities in the chemical, material, energy, pharmaceutical, and other industries. As recognized industry leaders in systems biology with worldwide commercial partnerships, Genomatica is enabling and accelerating the development of its customers’ bio-derived products and research programs. By implementing integrated computational/experimental platforms designed around its advanced award-winning modeling and simulation technologies, Genomatica performs research for its customers to rapidly develop next generation product development processes, and licenses proprietary technologies and intellectual property for use in its partners own laboratories. Genomatica is currently pursuing commercial relationships with major industrial biotechnology, chemical, energy and pharmaceutical companies seeking to leverage the power of systems biology for rapid development of biological and chemical products. For more information, please visit us on our website at www.genomatica.com.
Genomatica, Inc.
CONTACT: Christophe H. Schilling, Ph.D., President & Chief ScientificOfficer, or Amy Buono, Media Relations, both of Genomatica, Inc.,+1-858-824-1771
